Therapeutic incompatibilities – examples and management MCQs With Answer

Therapeutic incompatibilities are clinically important drug interactions that can be physical, chemical, pharmacokinetic or pharmacodynamic in nature. B.Pharm students must understand common examples—such as chelation of tetracyclines by calcium, IV precipitation of ceftriaxone with calcium-containing solutions, or severe hypotension when nitrates are combined with PDE5 inhibitors—and the management strategies including dose spacing, alternative agents, monitoring, Y‑site compatibility checks, pH adjustment, and appropriate storage. This topic covers mechanism, identification, prevention and documentation of interactions to ensure patient safety and drug stability. Mastery of these concepts supports rational prescribing, dispensing and IV administration in clinical practice. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What is the primary mechanism behind decreased oral absorption of tetracyclines when taken with milk?

• Enzymatic degradation by milk proteins
• Complexation (chelation) with divalent cations in milk
• Increased gastric motility
• Enhanced hepatic metabolism

Correct Answer: Complexation (chelation) with divalent cations in milk

Q2. Which of the following pairs is a classic example of an IV incompatibility causing visible precipitation?

• Vancomycin and normal saline
• Ceftriaxone and calcium-containing solutions
• Amoxicillin and dextrose 5% infusion
• Insulin and potassium chloride

Correct Answer: Ceftriaxone and calcium-containing solutions

Q3. A patient on digoxin develops ventricular arrhythmias after starting a loop diuretic. What pharmacodynamic interaction explains this?

• Loop diuretics increase digoxin clearance
• Loop diuretics cause hypokalemia increasing digoxin toxicity
• Loop diuretics induce CYP3A4 raising digoxin levels
• Loop diuretics chelate digoxin in the gut

Correct Answer: Loop diuretics cause hypokalemia increasing digoxin toxicity

Q4. Which management strategy reduces interaction risk between an enteral feeding formula and phenytoin?

• Administer phenytoin with the feeding tube flush immediately
• Hold enteral feed 1–2 hours before and after phenytoin dose
• Mix phenytoin directly into the feeding formula
• Increase phenytoin dose without monitoring

Correct Answer: Hold enteral feed 1–2 hours before and after phenytoin dose

Q5. Which describes a pharmacokinetic interaction?

• Synergistic hypotension when two vasodilators are used
• Drug A inducing CYP enzymes reducing Drug B plasma levels
• Precipitation when two IV drugs are mixed
• Antagonism at the same receptor by two drugs

Correct Answer: Drug A inducing CYP enzymes reducing Drug B plasma levels

Q6. What is the safest approach when two IV drugs are Y-site incompatible?

• Run both drugs simultaneously through the same line
• Administer the drugs sequentially with line flushes between
• Mix both drugs in one syringe to save time
• Reduce the infusion rate of both drugs

Correct Answer: Administer the drugs sequentially with line flushes between

Q7. Which antibiotic class commonly forms chelates with antacids and iron, reducing absorption?

• Beta-lactams
• Macrolides
• Fluoroquinolones
• Aminoglycosides

Correct Answer: Fluoroquinolones

Q8. Combining an ACE inhibitor with a potassium-sparing diuretic may lead to which adverse effect?

• Severe hypokalemia
• Hyperkalemia
• Profound metabolic alkalosis
• Excessive urinary sodium loss only

Correct Answer: Hyperkalemia

Q9. What is the best preventive measure for light-sensitive drugs prone to photodegradation?

• Store at high temperature
• Use amber or opaque containers and minimize light exposure
• Add water to dilute and stabilize
• Freeze the product routinely

Correct Answer: Use amber or opaque containers and minimize light exposure

Q10. Which interaction poses a life-threatening risk when nitrates are coadministered?

• Co-administration with ACE inhibitors
• Co-administration with PDE5 inhibitors (e.g., sildenafil)
• Co-administration with beta blockers
• Co-administration with digoxin

Correct Answer: Co-administration with PDE5 inhibitors (e.g., sildenafil)

Q11. Which monitoring parameter is most relevant when managing warfarin interactions?

• Serum creatinine only
• International Normalized Ratio (INR)
• Blood glucose
• Serum amylase

Correct Answer: International Normalized Ratio (INR)

Q12. Which practice helps prevent incompatibility when compounding IV admixtures?

• Assume compatibility if drug labels lack warnings
• Consult compatibility references and perform physical checks
• Always combine maximum recommended concentrations
• Use arbitrary diluents without approval

Correct Answer: Consult compatibility references and perform physical checks

Q13. Linezolid combined with SSRIs can cause which serious interaction?

• Hypoglycemia
• Serotonin syndrome
• Severe neutropenia immediately
• Profound renal toxicity

Correct Answer: Serotonin syndrome

Q14. What is the main reason for incompatibility when two drugs are mixed and a visible precipitate forms?

• Therapeutic synergy
• pH‑dependent solubility and salt formation
• Enhanced pharmacologic effect
• Increased osmolarity only

Correct Answer: pH‑dependent solubility and salt formation

Q15. Which action is advisable if an IV admixture shows unexpected cloudiness during administration?

• Continue infusion at reduced rate
• Stop infusion, replace tubing and assess for contamination or precipitation
• Ignore and document later
• Add another drug to clear the cloudiness

Correct Answer: Stop infusion, replace tubing and assess for contamination or precipitation

Q16. CYP3A4 inhibition by clarithromycin increases risk with which class of drugs leading to toxicity?

• Loop diuretics
• Statins metabolized by CYP3A4 (e.g., simvastatin)
• Hydrophilic antibiotics
• Low molecular weight heparins

Correct Answer: Statins metabolized by CYP3A4 (e.g., simvastatin)

Q17. For drugs unstable at low pH, which diluent should generally be avoided?

• Sodium bicarbonate solution
• Normal saline (pH ~5.5–7)
• Buffered alkaline solutions
• Dextrose 5% if acidic

Correct Answer: Dextrose 5% if acidic

Q18. Which is an effective management option when two oral drugs interact by chelation?

• Administer both together with food
• Separate dosing times by 2–4 hours
• Double the dose of one drug
• Stop monitoring drug levels

Correct Answer: Separate dosing times by 2–4 hours

Q19. What does Y-site compatibility testing determine?

• Oral absorption interactions
• Whether two IV drugs can be co-administered simultaneously through a common IV port
• Tissue distribution overlap
• Patient adherence risk

Correct Answer: Whether two IV drugs can be co-administered simultaneously through a common IV port

Q20. Combining metronidazole with alcohol may cause what reaction?

• Hypertensive crisis
• Disulfiram-like reaction (flushing, nausea)
• Serotonin syndrome
• Severe neutropenia

Correct Answer: Disulfiram-like reaction (flushing, nausea)

Q21. Which strategy reduces the risk of calcium-phosphate precipitation in parenteral nutrition?

• Mix calcium and phosphate at high concentrations in the same bag
• Add phosphate last and keep calcium concentration low, control pH and temperature
• Store admixture at high temperature to improve solubility
• Omit calcium entirely

Correct Answer: Add phosphate last and keep calcium concentration low, control pH and temperature

Q22. A pharmacist identifies a potential interaction between an MAOI and a sympathomimetic agent. What is the major clinical risk?

• Severe hypotension
• Hypertensive crisis
• Hyperglycemia
• Profound bradycardia

Correct Answer: Hypertensive crisis

Q23. Which documentation step is essential after identifying and managing a therapeutic incompatibility?

• Delete the patient record entry
• Record the interaction, actions taken, patient counseling and monitoring plan
• Inform only the pharmacy technician verbally
• Ignore if adverse effect did not occur

Correct Answer: Record the interaction, actions taken, patient counseling and monitoring plan

Q24. Which class of drugs is most likely to cause an increased bleeding risk when coadministered with NSAIDs?

• Antihistamines
• Anticoagulants (e.g., warfarin)
• Beta blockers
• Loop diuretics

Correct Answer: Anticoagulants (e.g., warfarin)

Q25. What is the preferred approach when a necessary IV drug is incompatible with the primary infusion fluid?

• Stop the primary infusion permanently
• Use a separate IV line or give the drug via a different route if possible
• Mix the drug into the primary infusion despite incompatibility
• Administer bolus without flushing

Correct Answer: Use a separate IV line or give the drug via a different route if possible

Q26. Which drug interaction exemplifies pharmacodynamic antagonism?

• Proton pump inhibitor reducing clopidogrel activation via CYP2C19
• Beta blocker antagonizing the effect of a beta-agonist bronchodilator
• Calcium reducing absorption of tetracycline
• Macrolide inhibiting statin metabolism via CYP3A4

Correct Answer: Beta blocker antagonizing the effect of a beta-agonist bronchodilator

Q27. Which of the following is a chemical incompatibility?

• Two drugs producing synergistic therapeutic effects
• Hydrolysis of an ester-containing drug in aqueous solution
• Altered absorption due to food
• Receptor blockade by an antagonist

Correct Answer: Hydrolysis of an ester-containing drug in aqueous solution

Q28. For drugs with narrow therapeutic index, which management is most important when starting interacting medications?

• Ignore and check only if symptoms occur
• Implement therapeutic drug monitoring and adjust dose accordingly
• Double the dosing interval without monitoring
• Switch to over-the-counter alternatives

Correct Answer: Implement therapeutic drug monitoring and adjust dose accordingly

Q29. Which factor most influences the likelihood of two drugs being physically incompatible in solution?

• Their therapeutic class only
• Chemical structure, pH, ionic strength and concentration
• Patient age alone
• Packaging color

Correct Answer: Chemical structure, pH, ionic strength and concentration

Q30. What is a practical step pharmacists can take to minimize medication incompatibilities in hospital IV therapy?

• Maintain an up-to-date IV compatibility reference and educate staff on administration protocols
• Rely solely on oral alternatives for all IV drugs
• Allow nursing staff to mix incompatible drugs for convenience
• Discard compatibility data as irrelevant

Correct Answer: Maintain an up-to-date IV compatibility reference and educate staff on administration protocols

Download